Document is current
Any future updates will be listed below
-
Authors
Ghai, Sangeet https://orcid.org/0000-0001-9451-0594
Ni, Tiffany T.
Pavlovich, Christian P.
Futterer, Jurgen J.
Schade, George R.
Sanchez-Salas, Rafael
Cornud, Francois
Eggener, Scott
Feller, John F.
George, Arvin K.
Villers, Arnauld
de la Rosette, Jean https://orcid.org/0000-0002-6308-1763
-
Funding
Funding for this research was provided by:
American Cancer Society (RSG2117101)
- License Information
-
More Information
Article History
Received: 14 May 2024
Revised: 7 February 2025
Accepted: 24 February 2025
First Online: 27 March 2025
Competing interests
: SG served as Principal Investigator for Phase I and Phase II studies assessing MRgFUS sponsored by Insightec Ltd. GS currently serves as a consultant to EDAP Technomed Inc., an advisor to Immunity Bio, owns intellectual property licensed to Petal Surgical, and his work has been funded by the NIH (NIH R01DK119310 and R01CA258581) and American Cancer Society (RSG2117101). SE previously served as a member of the medical advisory board for Profound Medical approximately from the years 2016-2020. All other co-authors declare no potential competing interests.
